Clinical Trial Update: The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs [Phase 2]

View source ↗

Summary

Phase 2 trial update on optimizing antiemetic regimen for radiotherapy-induced nausea and vomiting in locally advanced head and neck squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Nausea
• Vomiting

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Nausea, Vomiting | Phase 2 | Status: UNKNOWN